Bedside Monitoring to Identify Impaired Cerebral Autoregulation in Women with Postpartum Hypertension
NIRS-Based Bedside Monitoring to Identify Impaired Cerebral Autoregulation in Women with Postpartum Hypertension
2 other identifiers
observational
5
1 country
1
Brief Summary
The purpose of this research study is to develop a protocol for NIRS-based bedside monitoring to identify impaired cerebral autoregulation in women admitted to the high-risk obstetrics unit with postpartum hypertension. The investigators will then pilot this protocol in 10 patients with high-risk neurological features, such as headache.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 13, 2021
CompletedFirst Submitted
Initial submission to the registry
December 1, 2021
CompletedFirst Posted
Study publicly available on registry
December 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2023
CompletedSeptember 23, 2024
September 1, 2024
1.6 years
December 1, 2021
September 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Oxygenated hemoglobin concentration
The Edwards HemoSphere system with ForeSight Elite NIRS component (Edwards LifeSciences) will be used to monitor oxygenated and deoxygenated hemoglobin concentrations. Two adhesive NIRS probes will be placed on the frontotemporal scalp covering the cortex, usually supplied by the middle cerebral artery. \[Describe how the concentration will be obtained, the range of anticipated concentrations, and how to interpret the concentrations - eg, higher concentrations indicate ...\]
Continuously collected for up to 24 hours
Deoxygenated hemoglobin concentration
The Edwards HemoSphere system with ForeSight Elite NIRS component (Edwards LifeSciences) will be used to monitor oxygenated and deoxygenated hemoglobin concentrations. Two adhesive NIRS probes will be placed on the frontotemporal scalp covering the cortex, usually supplied by the middle cerebral artery.
Continuously collected for up to 24 hours
Blood pressure (BP)
Continuous non-invasive BP monitoring will be utilized (ClearSight finger cuff system, Edwards LifeSciences).
Continuously collected for up to 24 hours
Study Arms (1)
Post-delivery preeclampsia patients
Women admitted to the high-risk unit(s) with elevated blood pressure and neurological symptoms, such as headache, after delivery.
Eligibility Criteria
Study participants will be recruited from the high-risk inpatient obstetrics unit at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center. Women who have given birth within the previous 12 weeks and are admitted to the high-risk inpatient obstetrics unit for management of hypertension will be screened.
You may qualify if:
- Women who have given birth within the previous 12 weeks
- Admitted to the high-risk inpatient obstetrics unit for management of hypertension
- With headache or other neurological symptoms such as vision changes
You may not qualify if:
- Acute ischemic stroke
- Intracerebral or subarachnoid hemorrhage
- Eclamptic seizures
- Any other neurological complication requiring transfer to the neurological intensive care unit or stroke stepdown unit
- History of Reynaud's syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital (NYP)
New York, New York, 10032, United States
Related Publications (1)
Petersen NH, Silverman A, Strander SM, Kodali S, Wang A, Sansing LH, Schindler JL, Falcone GJ, Gilmore EJ, Jasne AS, Cord B, Hebert RM, Johnson M, Matouk CC, Sheth KN. Fixed Compared With Autoregulation-Oriented Blood Pressure Thresholds After Mechanical Thrombectomy for Ischemic Stroke. Stroke. 2020 Mar;51(3):914-921. doi: 10.1161/STROKEAHA.119.026596. Epub 2020 Feb 12.
PMID: 32078493BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eliza Miller, MD
Columbia University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Neurology in the Division of Stroke and Cerebrovascular Disease
Study Record Dates
First Submitted
December 1, 2021
First Posted
December 14, 2021
Study Start
August 13, 2021
Primary Completion
March 13, 2023
Study Completion
March 13, 2023
Last Updated
September 23, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share